Xia Tao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xia Tao has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Feng Zhang
Department of Pharmacy, Changzheng Hospital, Naval Medical University, Shanghai, China
2 shared publications - Wansheng Chen
The SATCM Key Laboratory for New Resources & Quality Evaluation of Chinese Medicine, Institute of Chinese Materia Medica Shanghai University of Traditional Chinese Medicine Shanghai 201203 China
2 shared publications - Cuiyun Huang
Department of Pharmacy, Changzheng Hospital, Naval Medical University (Second Military Medical University), Shanghai 200003, China
1 shared publication - Depei Wu
National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Jiangsu Key Laboratory of Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, China
1 shared publication Dou-Dou Huang
The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China
1 shared publicationFeng Zhang
Department of Pharmacy, Changzheng Hospital, Naval Medical University, Shanghai, China
1 shared publication
Latest Publications
- Open Access
- 23 May 2024
- Published by Wolters Kluwer Health in World Journal of Traditional Chinese Medicine
- Vol. 11 (1) , 23-44
Rapid Classification and Identification of Chemical Compounds and Semi-Quantitative Metabolism of Huangkui Capsules and the Protective Effects of Its Quercetin Derivatives against Tacrolimus-Induced HK-Cell Reduction
Objective: The study aimed to establish an effective strategy for systematically characterizing and verifying compounds in Huangkui capsules (HKCs). Materials and Methods: An ultrahigh-performance liquid chromatography quadrupole time-of-flight mass spectrometry (MS) method was effectively established and utilized for the chemical compound characterization in HKC, with the support of MS-DIAL, MS-FINDER, and Global Natural Product Social Molecular Network. Multiple rat samples were analyzed after the oral administration. Metabolites were identified based on specific cleavage behaviors, and metabolic pathways were predicted. Semi-quantitative analysis of the metabolome profiles was conducted using post-data processing. High concentrations in vivo were investigated for their role in tacrolimus-induced death of HK-2 cells. Results: In total, 129 compounds were identified in HKC, of which 74 were reported for the first time. In this study, we successfully identified and uncovered 19 prototypes and 123 metabolites from the biosamples. The concentrations of glucuronidation and methylation metabolites of quercetin were the highest in the kidney and intestinal tissues. In contrast, significant glucuronidation of quercetin metabolites was observed with high blood concentrations. Notably, quercetin glucuronidation and methylation metabolites protected HK-cell against tacrolimus-induced injury in a dose-dependent manner. Conclusions: This study successfully established a reliable and efficient strategy for comprehensive characterization of traditional Chinese medicine compounds. This strategy harnessed the power of various intelligent postprocessing technologies to provide a more thorough understanding of active components and their metabolic transformations in the body. These results suggest that quercetin metabolites should be evaluated for their protective capacity against kidney disease.
- 23 May 2024
- Published by Wolters Kluwer Health in World Journal of Traditional Chinese Medicine
- Vol. 11 (1) , 23-44
Open AccessRapid Classification and Identification of Chemical Compounds and Semi-Quantitative Metabolism of Huangkui Capsules and the Protective Effects of Its Quercetin Derivatives against Tacrolimus-Induced HK-Cell Reduction
Objective: The study aimed to establish an effective strategy for systematically characterizing and verifying compounds in Huangkui capsules (HKCs). Materials and Methods: An ultrahigh-performance liquid chromatography quadrupole time-of-flight mass spectrometry (MS) method was effectively established and utilized for the chemical compound characterization in HKC, with the support of MS-DIAL, MS-FINDER, and Global Natural Product Social Molecular Network. Multiple rat samples were analyzed after the oral administration. Metabolites were identified based on specific cleavage behaviors, and metabolic pathways were predicted. Semi-quantitative analysis of the metabolome profiles was conducted using post-data processing. High concentrations in vivo were investigated for their role in tacrolimus-induced death of HK-2 cells. Results: In total, 129 compounds were identified in HKC, of which 74 were reported for the first time. In this study, we successfully identified and uncovered 19 prototypes and 123 metabolites from the biosamples. The concentrations of glucuronidation and methylation metabolites of quercetin were the highest in the kidney and intestinal tissues. In contrast, significant glucuronidation of quercetin metabolites was observed with high blood concentrations. Notably, quercetin glucuronidation and methylation metabolites protected HK-cell against tacrolimus-induced injury in a dose-dependent manner. Conclusions: This study successfully established a reliable and efficient strategy for comprehensive characterization of traditional Chinese medicine compounds. This strategy harnessed the power of various intelligent postprocessing technologies to provide a more thorough understanding of active components and their metabolic transformations in the body. These results suggest that quercetin metabolites should be evaluated for their protective capacity against kidney disease.
- Open Access
- 5 September 2023
- Published by Springer Nature in Blood Cancer Journal
- Vol. 13 (1) , 1-4
Cell-free DNA chromosome copy number variations predict outcomes in plasma cell myeloma
- 5 September 2023
- Published by Springer Nature in Blood Cancer Journal
- Vol. 13 (1) , 1-4
Open AccessCell-free DNA chromosome copy number variations predict outcomes in plasma cell myeloma
- Open Access
- 1 June 2022
- Published by AME Publishing Company in Translational Pediatrics
- Vol. 11 (6) , 834-847
Pharmaceutical services based on therapeutic care pathway for kidney transplantation from donors of infants and young children: a single-center experience
Pharmaceutical services based on therapeutic care pathway for kidney transplantation from donors of infants and young children: a single-center experience Yan Wen, Mengpei Zhao, Shangxi Fu, Zhichun Gu, Wansheng Chen, Qing Zhao, Wei Shu, Xia Tao, Feng Zhang
- 1 June 2022
- Published by AME Publishing Company in Translational Pediatrics
- Vol. 11 (6) , 834-847
Open AccessPharmaceutical services based on therapeutic care pathway for kidney transplantation from donors of infants and young children: a single-center experience
Pharmaceutical services based on therapeutic care pathway for kidney transplantation from donors of infants and young children: a single-center experience Yan Wen, Mengpei Zhao, Shangxi Fu, Zhichun Gu, Wansheng Chen, Qing Zhao, Wei Shu, Xia Tao, Feng Zhang
- Open Access
- 1 December 2021
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 144, 112354
Evaluation of the effect of Shengxian Decoction on doxorubicin-induced chronic heart failure model rats and a multicomponent comparative pharmacokinetic study after oral administration in normal and model rats
- 1 December 2021
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 144, 112354
Open AccessEvaluation of the effect of Shengxian Decoction on doxorubicin-induced chronic heart failure model rats and a multicomponent comparative pharmacokinetic study after oral administration in normal and model rats